Six researchers from MD Anderson elected as AAAS Fellows
In recognition of their contributions to basic, translational, and clinical research, six faculty members from The University of Texas MD Anderson Cancer Center have been named Fellows of the American Association for the Advancement of Science (AAAS). Election as a Fellow, a tradition that began in 1874, is an honor bestowed upon AAAS members by their peers. MD Anderson’s faculty now includes 46 AAAS Fellows...
Seres Therapeutics, MD Anderson Cancer Center, and the Parker Institute for Cancer Immunotherapy Announce a Collaboration to Support the Investigation of Microbiome Therapeutics for Immuno-Oncology
Seres Therapeutics, Inc., The University of Texas MD Anderson Cancer Center and the Parker Institute for Cancer Immunotherapy today...
Thousands support MD Anderson’s Boot Walk to End Cancer®
Thousands of patients, family members, volunteers, friends and employees of The University of Texas MD Anderson Cancer Center participated...
Seven leaders join MD Anderson Cancer Center Board of Visitors
The University of Texas MD Anderson Cancer Center Board of Visitors (BOV) welcomed seven new members at its annual meeting today. They include Randy A. Foutch of Tulsa, Oklahoma; Winell Herron of Bellaire, Texas; Isabella Arjona-Zappala of New York; and R. Stan Marek Jr., Walker N. Moody, Jerry Simon, and Cyvia Wolff of Houston.
“We are delighted to welcome these exemplary new members who have chosen to devote their time,...
Circulating tumor cells associated with relapse in late-stage melanoma patients
A study revealing a connection between circulating tumor cells (CTCs) and relapse in stage IV melanoma patients points to liquid biopsy as...